BACKGROUND: Non-Hodgkin lymphoma (NHL) is a malignancy of lymphocytes, and there is growing evidence for a role of germline genetic variation in immune genes in NHL etiology. METHODS: To identify susceptibility immune genes, we conducted a 2-stage analysis of single-nucleotide polymorphisms (SNP) from 1,253 genes using the Immune and Inflammation Panel. In Stage 1, we genotyped 7,670 SNPs in 425 NHL cases and 465 controls, and in Stage 2 we genotyped the top 768 SNPs on an additional 584 cases and 768 controls. The association of individual SNPs with NHL risk from a log-additive model was assessed using the OR and 95% confidence intervals (CI). RESULTS: In the pooled analysis, only the TAP2 coding SNP rs241447 (minor allele frequency = 0.26; Thr655Ala) at 6p21.3 (OR = 1.34, 95% CI 1.17-1.53) achieved statistical significance after accounting for multiple testing (P = 3.1 × 10(-5)). The TAP2 SNP was strongly associated with follicular lymphoma (FL, OR = 1.82, 95%CI 1.46-2.26; p = 6.9 × 10(-8)), and was independent of other known loci (rs10484561 and rs2647012) from this region. The TAP2 SNP was also associated with diffuse large B-cell lymphoma (DLBCL, OR = 1.38, 95% CI 1.08-1.77; P = 0.011), but not chronic lymphocytic leukemia (OR = 1.08; 95% CI 0.88-1.32). Higher TAP2 expression was associated with the risk allele in both FL and DLBCL tumors. CONCLUSION: Genetic variation in TAP2 was associated with NHL risk overall, and FL risk in particular, and this was independent of other established loci from 6p21.3. IMPACT: Genetic variation in antigen presentation of HLA class I molecules may play a role in lymphomagenesis. 2012 AACR
BACKGROUND:Non-Hodgkin lymphoma (NHL) is a malignancy of lymphocytes, and there is growing evidence for a role of germline genetic variation in immune genes in NHL etiology. METHODS: To identify susceptibility immune genes, we conducted a 2-stage analysis of single-nucleotide polymorphisms (SNP) from 1,253 genes using the Immune and Inflammation Panel. In Stage 1, we genotyped 7,670 SNPs in 425 NHL cases and 465 controls, and in Stage 2 we genotyped the top 768 SNPs on an additional 584 cases and 768 controls. The association of individual SNPs with NHL risk from a log-additive model was assessed using the OR and 95% confidence intervals (CI). RESULTS: In the pooled analysis, only the TAP2 coding SNP rs241447 (minor allele frequency = 0.26; Thr655Ala) at 6p21.3 (OR = 1.34, 95% CI 1.17-1.53) achieved statistical significance after accounting for multiple testing (P = 3.1 × 10(-5)). The TAP2 SNP was strongly associated with follicular lymphoma (FL, OR = 1.82, 95%CI 1.46-2.26; p = 6.9 × 10(-8)), and was independent of other known loci (rs10484561 and rs2647012) from this region. The TAP2 SNP was also associated with diffuse large B-cell lymphoma (DLBCL, OR = 1.38, 95% CI 1.08-1.77; P = 0.011), but not chronic lymphocytic leukemia (OR = 1.08; 95% CI 0.88-1.32). Higher TAP2 expression was associated with the risk allele in both FL and DLBCL tumors. CONCLUSION: Genetic variation in TAP2 was associated with NHL risk overall, and FL risk in particular, and this was independent of other established loci from 6p21.3. IMPACT: Genetic variation in antigen presentation of HLA class I molecules may play a role in lymphomagenesis. 2012 AACR
Authors: Matthew S Forrest; Christine F Skibola; Tracy J Lightfoot; Paige M Bracci; Eleanor V Willett; Martyn T Smith; Elizabeth A Holly; Eve Roman Journal: Br J Haematol Date: 2006-06-01 Impact factor: 6.998
Authors: Jennifer L Kelly; Anne J Novak; Zachary S Fredericksen; Mark Liebow; Stephen M Ansell; Ahmet Dogan; Alice H Wang; Thomas E Witzig; Timothy G Call; Neil E Kay; Thomas M Habermann; Susan L Slager; James R Cerhan Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-09-20 Impact factor: 4.254
Authors: Sophia S Wang; Idan Menashe; James R Cerhan; Wendy Cozen; Richard K Severson; Scott Davis; Amy Hutchinson; Nathaniel Rothman; Stephen J Chanock; Leslie Bernstein; Patricia Hartge; Lindsay M Morton Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-12-10 Impact factor: 4.254
Authors: Anne J Novak; Susan L Slager; Zachary S Fredericksen; Alice H Wang; Michelle M Manske; Steven Ziesmer; Mark Liebow; William R Macon; Stacey R Dillon; Thomas E Witzig; James R Cerhan; Stephen M Ansell Journal: Cancer Res Date: 2009-04-21 Impact factor: 12.701
Authors: K S Rønningen; D E Undlien; R Ploski; N Maouni; R J Konrad; E Jensen; E Hornes; H Reijonen; M Colonna; D S Monos Journal: Eur J Immunol Date: 1993-05 Impact factor: 5.532
Authors: James R Cerhan; Anne J Novak; Zachary S Fredericksen; Alice H Wang; Mark Liebow; Timothy G Call; Ahmet Dogan; Thomas E Witzig; Stephen M Ansell; Thomas M Habermann; Neil E Kay; Susan L Slager Journal: Br J Haematol Date: 2009-03-30 Impact factor: 6.998
Authors: Lucia Conde; Eran Halperin; Nicholas K Akers; Kevin M Brown; Karin E Smedby; Nathaniel Rothman; Alexandra Nieters; Susan L Slager; Angela Brooks-Wilson; Luz Agana; Jacques Riby; Jianjun Liu; Hans-Olov Adami; Hatef Darabi; Henrik Hjalgrim; Hui-Qi Low; Keith Humphreys; Mads Melbye; Ellen T Chang; Bengt Glimelius; Wendy Cozen; Scott Davis; Patricia Hartge; Lindsay M Morton; Maryjean Schenk; Sophia S Wang; Bruce Armstrong; Anne Kricker; Sam Milliken; Mark P Purdue; Claire M Vajdic; Peter Boyle; Qing Lan; Shelia H Zahm; Yawei Zhang; Tongzhang Zheng; Nikolaus Becker; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Katja Butterbach; Pierluigi Cocco; Lenka Foretova; Marc Maynadié; Silvia de Sanjosé; Anthony Staines; John J Spinelli; Sara J Achenbach; Timothy G Call; Nicola J Camp; Martha Glenn; Neil E Caporaso; James R Cerhan; Julie M Cunningham; Lynn R Goldin; Curtis A Hanson; Neil E Kay; Mark C Lanasa; Jose F Leis; Gerald E Marti; Kari G Rabe; Laura Z Rassenti; Logan G Spector; Sara S Strom; Celine M Vachon; J Brice Weinberg; Elizabeth A Holly; Stephen Chanock; Martyn T Smith; Paige M Bracci; Christine F Skibola Journal: Nat Genet Date: 2010-07-18 Impact factor: 38.330
Authors: Yucai Wang; Thomas M Habermann; Sophia S Wang; Matthew J Maurer; Vivekananda Sarangi; Brian K Link; Andrew L Feldman; David J Inwards; Thomas E Witzig; Wendy Cozen; Nathaniel Rothman; Yan Asmann; Susan L Slager; James R Cerhan Journal: Am J Hematol Date: 2019-03-15 Impact factor: 10.047
Authors: Eleanor Kane; Christine F Skibola; Paige M Bracci; James R Cerhan; Laura Costas; Karin Ekström Smedby; Elizabeth A Holly; Marc Maynadié; Anne J Novak; Tracy J Lightfoot; Stephen M Ansell; Alex G Smith; Mark Liebow; Mads Melbye; Lindsay Morton; Silvia de Sanjosé; Susan L Slager; Sophia S Wang; Yawei Zhang; Tongzhang Zheng; Eve Roman Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-11 Impact factor: 4.254
Authors: Lindsay M Morton; Joshua N Sampson; James R Cerhan; Jennifer J Turner; Claire M Vajdic; Sophia S Wang; Karin E Smedby; Silvia de Sanjosé; Alain Monnereau; Yolanda Benavente; Paige M Bracci; Brian C H Chiu; Christine F Skibola; Yawei Zhang; Sam M Mbulaiteye; Michael Spriggs; Dennis Robinson; Aaron D Norman; Eleanor V Kane; John J Spinelli; Jennifer L Kelly; Carlo La Vecchia; Luigino Dal Maso; Marc Maynadié; Marshall E Kadin; Pierluigi Cocco; Adele Seniori Costantini; Christina A Clarke; Eve Roman; Lucia Miligi; Joanne S Colt; Sonja I Berndt; Andrea Mannetje; Anneclaire J de Roos; Anne Kricker; Alexandra Nieters; Silvia Franceschi; Mads Melbye; Paolo Boffetta; Jacqueline Clavel; Martha S Linet; Dennis D Weisenburger; Susan L Slager Journal: J Natl Cancer Inst Monogr Date: 2014-08
Authors: Shehnaz K Hussain; Solomon B Makgoeng; Matthew J Everly; Marc T Goodman; Otoniel Martínez-Maza; Lindsay M Morton; Christina A Clarke; Charles F Lynch; Jon Snyder; Ajay Israni; Bertram L Kasiske; Eric A Engels Journal: Transplantation Date: 2016-11 Impact factor: 5.385
Authors: Niquelle Brown Wadé; Cindy M Chang; David Conti; Joshua Millstein; Christine Skibola; Alexandra Nieters; Sophia S Wang; Silvia De Sanjose; Eleanor Kane; John J Spinelli; Paige Bracci; Yawei Zhang; Susan Slager; Jun Wang; Henrik Hjalgrim; Karin Ekstrom Smedby; Elizabeth E Brown; Ruth F Jarrett; Wendy Cozen Journal: Cancer Causes Control Date: 2020-03-02 Impact factor: 2.532
Authors: Kaspar René Nielsen; Rudi Steffensen; Mette Dahl Bendtsen; Maria Rodrigo-Domingo; John Baech; Thure Mors Haunstrup; Kim Steve Bergkvist; Alexander Schmitz; Julie Stoeveve Boedker; Preben Johansen; Karen Dybkaeær; Martin Boeøgsted; Hans Erik Johnsen Journal: PLoS One Date: 2015-10-08 Impact factor: 3.240
Authors: Unhee Lim; Jonathan M Kocarnik; William S Bush; Tara C Matise; Christian Caberto; Sungshim Lani Park; Christopher S Carlson; Ewa Deelman; David Duggan; Megan Fesinmeyer; Christopher A Haiman; Brian E Henderson; Lucia A Hindorff; Laurence N Kolonel; Ulrike Peters; Daniel O Stram; Maarit Tiirikainen; Lynne R Wilkens; Chunyuan Wu; Charles Kooperberg; Loïc Le Marchand Journal: PLoS One Date: 2014-03-05 Impact factor: 3.240
Authors: Jonathan D Mosley; Sara L Van Driest; Emma K Larkin; Peter E Weeke; John S Witte; Quinn S Wells; Jason H Karnes; Yan Guo; Lisa Bastarache; Lana M Olson; Catherine A McCarty; Jennifer A Pacheco; Gail P Jarvik; David S Carrell; Eric B Larson; David R Crosslin; Iftikhar J Kullo; Gerard Tromp; Helena Kuivaniemi; David J Carey; Marylyn D Ritchie; Josh C Denny; Dan M Roden Journal: PLoS One Date: 2013-12-12 Impact factor: 3.240
Authors: Kristina B Lundin-Ström; Andrea Biloglav; Henrik Lilljebjörn; Marianne Rissler; Thoas Fioretos; Markus Hansson; Mikael Behrendtz; Anders Castor; Linda Olsson; Bertil Johansson Journal: Leukemia Date: 2018-07-02 Impact factor: 11.528